December 6, 2016
Embassy Suites by Hilton Boston at Logan Airport, Boston, MA
Le Cong Ph.D.
Postdoctoral Associate Broad Institute, MIT
Dr. Le Cong obtained his B.S. with highest honor from Tsinghua University, his Ph.D. from Harvard University, and is currently a Postdoctoral Associate at the Broad Institute of MIT and Harvard. He completed thesis work mainly in Dr. Feng Zhang’s lab, where he did pioneering studies on genetic and epigenetic engineering, focusing on developing technologies based on TALE and CRISPR-Cas systems and adapting them for gene therapy applications. His work was the first to demonstrate CRISPR-Cas9 genome editing in eukaryotic cells (Cong et al. Science. 2013), and is co-inventor of multiple patents on related technologies. He is now working on single-cell genomics and systems biology in Dr. Aviv Regev's group. He has published in many high-impact journals including Science, Nature, Cell, Nature Biotechnology, and written for Springer’s Book Series Neuromethods and Methods in Molecular Biology. He is recipient of multiple awards and fellowships including the HHMI International Student Research Fellowship, the CRI Irvington Postdoctoral Fellowships Award, among others